'It illustrates the potential of G 2 checkpoint abrogators to preferentially sensitize p53-mutated, treatment resistant tumor cells for genotoxic treatment.'
'The effective stimulation of the G2 / M transition by G2 block abrogators and continued processing of DNA by endoreplication and delayed movement from S to G2 may be a condition which compromises cells for subsequent damage.'
